Elenco degli articoli con argomento «dermatite atopica»
Dermatologia19 set 2022
Nuove terapie migliorano qualità della vita e fanno risparmiare.
Con le nuove terapie, però, si aprono nuovi scenari, per i pazienti e per il Ssn
27 giu 2022
Probiotics for the prevention of atopic dermatitis
BackgroundAtopic dermatitis (AD) is a common skin disease during infancy
22 giu 2022
La gestione dei pazienti con dermatite atopica
Monografia SIDeMaST
23 mag 2022
Subtypes of atopic dermatitis
Atopic dermatitis (AD) is a heterogenous disorder and can be classified into different types.
16 mag 2022
Contact allergy in children with and without atopic dermatitis
Contact allergy and atopic dermatitis (AD) are both common inflammatory T cell-mediated diseases and many factors may influence the prevalence of contact allergy in AD patients
09 mag 2022
Moderate-to-severe atopic dermatitis in adolescents
Moderate-to-severe atopic dermatitis (AD) in the adolescence is a high burden disease and its treatment can be very challenging
14 mar 2022
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis
Primary results from the Measure Up 1 and Measure Up 2 studies demonstrated upadacitinib efficacy and safety through 16 weeks in patients with atopic dermatitis.
07 feb 2022
Increased expression of Filaggrin and Claudin-1 in the ocular surface
Atopic dermatitis (AD) is an itchy, chronic and inflammatory skin condition, with dysfunctional immune response and skin barrier defects.
31 gen 2022
The Impact of Childhood Atopic Dermatitis
The Impact of Childhood Atopic Dermatitis on Life Decisions for Caregivers and Families
20 dic 2021
Atopic dermatitis associated with autoimmune, cardiovascular and mental health comorbidities
Previous studies have reported conflicting estimates of associations between atopic dermatitis (AD) and autoimmune, cardiovascular and mental health comorbidities.
14 ott 2021
Psoriasi e dermatite atopica indicazioni dei dermatologi
Le nuove chances terapeutiche per eliminare le lesioni cutanee e mitigare il prurito, al centro della seconda giornata di lavori del Congresso della Società Italiana di Dermatologia e delle Malattie Sessualmente Trasmesse.
11 ott 2021
Phase 2a randomized clinical trial of dupilumab
Treatments for alopecia areata (AA) patients with extensive scalp hair loss are limited
05 ott 2021
Improvement in symptoms of anxiety and depression in patients
Improvement in symptoms of anxiety and depression in patients with atopic dermatitis after treatment with baricitinib
05 ott 2021
Feelings of guilt in parents of children with atopic dermatitis
Feelings of guilt may be associated with illness. Patients may feel responsible for their disease
05 lug 2021
The Role of Type 2 Innate Lymphoid Cells in Allergic Diseases
Allergic diseases are significant diseases that affect many patients worldwide.
07 giu 2021
Once-daily upadacitinib versus placebo in adolescents and adults
Upadacitinib is an oral Janus kinase (JAK) inhibitor with greater inhibitory potency for JAK1 than JAK2, JAK3, and tyrosine kinase 2.
26 apr 2021
Atopic Dermatitis and Infertility
Given that common pathophysiological factors play a role in atopic dermatitis (AD) and infertility
16 apr 2021
Impact of baricitinib in combination with topical steroids
Baricitinib is an oral, selective, reversible Janus kinase 1/2 inhibitor approved in the European Union and Japan and under investigation in the United States for treatment of atopic dermatitis (AD).
29 mar 2021
Tralokinumab for atopic dermatitis
Tralokinumab for atopic dermatitis
23 mar 2021
Biomarkers in atopic dermatitis
Atopic dermatitis (AD) is a common yet complex skin disease, posing a therapeutic challenge with increasingly recognized different phenotypes among variable patient populations.